Literature DB >> 8097089

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.

A J Kenny1, A Bourne, J Ingram.   

Abstract

Endopeptidase-24.11 (E-24.11, EC 3.4.24.11) is widely believed to play a physiological role in metabolizing atrial natriuretic peptide (ANP). Since the discovery of ANP, new natriuretic peptides have been isolated and other peptides synthesized as receptor ligands. The hydrolysis in vitro of six related peptides by the endopeptidase has been studied, mainly by h.p.l.c. The initial attack on the 32-residue form of pig brain natriuretic peptide (pBNP-32) was shown to be at the Ser20-Leu21 bond, as had been previously shown for the 26-residue form. In contrast, human brain natriuretic peptide-32 (hBNP-32), which differs in ten residues from pBNP-32, was attacked first at the Met4-Val5 bond, releasing the N-terminal tetrapeptide, and only later at bonds within the ring: at Arg17-Ile18 and subsequently at four other sites. Urodilatin, which has a four-residue extension at the N-terminus compared with alpha-human atrial natriuretic peptide-28 (alpha-hANP), was degraded at about half the rate of the latter, though the C-terminal Phe-Arg-Tyr was released at the same rate. The 22-residue C-type natriuretic peptide was hydrolysed more rapidly than alpha-hANP, as were two C-receptor ligands (peptides with deletions within the ring): C-ANP4-23 (rANP4-23 des-Gln18,Ser19,Gly20,Leu21,Gly22) and SC 46542 (hANP5-28 des-Phe8,Gly9,Ala17,Gln18). Angiotensin-converting enzyme failed to hydrolyse pBNP-32, hBNP-32 or 125I-rat (r) ANP, even after prolonged incubation. Km and kcat values were determined for the hydrolysis of alpha-hANP, porcine BNP-26, porcine BNP-32 and 125I-rANP by E-24.11. Ki values were determined for six peptides, alpha-hANP, urodilatin, hBNP-32, C-type natriuretic peptide (CNP), SC 46542 and C-type natriuretic peptide (C-ANP4-23), in radiometric assays of E-24.11 with either [125I] insulin B chain or [125I] rANP as substrate. The Ki values (2.5-13 microM) for CNP were the lowest of any of the group, whereas those for hBNP-32 (151-172 microM) were the highest. The physiological significance of these results is discussed, especially in regard to the relative resistance of hBNP-32 to attack and the ability of the C-receptor ligands to compete with natriuretic peptides for hydrolysis by E-24.11.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097089      PMCID: PMC1132484          DOI: 10.1042/bj2910083

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

2.  Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells.

Authors:  R M Scarborough; D B Schenk; G A McEnroe; A Arfsten; L L Kang; K Schwartz; J A Lewicki
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

3.  A new natriuretic peptide in porcine brain.

Authors:  T Sudoh; K Kangawa; N Minamino; H Matsuo
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

4.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).

Authors:  K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

5.  The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

Authors:  S L Stephenson; A J Kenny
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

6.  The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

Authors:  R Matsas; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

7.  Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung.

Authors:  T Kuno; J W Andresen; Y Kamisaki; S A Waldman; L Y Chang; S Saheki; D C Leitman; M Nakane; F Murad
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

8.  Metabolism of neuropeptides. Hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes.

Authors:  S L Stephenson; A J Kenny
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

9.  Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide.

Authors:  Y Ogawa; K Nakao; M Mukoyama; K Hosoda; G Shirakami; H Arai; Y Saito; S Suga; M Jougasaki; H Imura
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

10.  Augmented secretion of brain natriuretic peptide in acute myocardial infarction.

Authors:  M Mukoyama; K Nakao; K Obata; M Jougasaki; M Yoshimura; E Morita; K Hosoda; S Suga; Y Ogawa; H Yasue
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

View more
  61 in total

1.  B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

Authors:  P Welsh; J J McMurray
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

2.  A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.

Authors:  Paul M McKie; Alessandro Cataliotti; Guido Boerrigter; Horng H Chen; S Jeson Sangaralingham; Fernando L Martin; Tomoko Ichiki; John C Burnett
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

3.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 4.  Nesiritide: a review of its use in acute decompensated heart failure.

Authors:  Gillian M Keating; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 6.  Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.

Authors:  Paul M McKie; John C Burnett
Journal:  Curr Heart Fail Rep       Date:  2015-02

7.  Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?

Authors:  Naveen L Pereira; Viral K Desai; Allan S Jaffe
Journal:  Eur J Heart Fail       Date:  2019-03-04       Impact factor: 15.534

8.  Human B-type natriuretic peptide is not degraded by meprin A.

Authors:  Deborah M Dickey; Lincoln R Potter
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 9.  Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

Authors:  Scott A Hubers; Nancy J Brown
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

10.  Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

Authors:  Candace Y W Lee; Brenda K Huntley; Daniel J McCormick; Tomoko Ichiki; S Jeson Sangaralingham; Ondrej Lisy; John C Burnett
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.